You are here: All Products  > Antengene Completes $340 Million Hong Kong IPO for Oncology Drugs

Antengene Completes $340 Million Hong Kong IPO for Oncology Drugs

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products